4//SEC Filing
NANOGEN INC 4
Accession 0001181431-05-034357
CIK 0001030339operating
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 6:13 PM ET
Size
6.1 KB
Accession
0001181431-05-034357
Insider Transaction Report
Form 4
NANOGEN INCNGEN
SCHREIBER DAVID
Director
Transactions
- Award
Common Stock
2005-06-09$3.67/sh+6,812$25,000→ 13,079 total
Holdings
- 25,000
Non_Qualified Stock Option
Exercise: $4.07Exp: 2013-06-12→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]25% of the shares become exercisable one year from date of grant, and the remainder become exercisable ratably on a monthly basis subsequent to that date ending four years from date of grant.
Documents
Issuer
NANOGEN INC
CIK 0001030339
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001030339
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 6:13 PM ET
- Size
- 6.1 KB